Lensar - W/I (LNSR)
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the ma...
- Open
- 5.950
- High
- 6.110
- Low
- 5.900
- Prev. Close
- 6.020
- Volume
- 44.97K
- Turnover
- 271.44K
- Avg Price
- 6.036
- Bid/Ask Ratio
- 60.00%
- Amplitude
- 3.49%
- 52wk High
- 13.080
- Volume Ratio
- 1.18
- Turnover Ratio
- 0.51%
Lensar - W/I Analyst Rating
View moreForecast & Rating
Jul 13, 2026Price forecast
$8.5040.96%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 1 day ago, 03:18 PM
LENSAR holds annual shareholder meeting
- PUBT · Aug 6 at 07:04 AM
LENSAR to report Q2 2026 results, host conference call
- Tip Ranks · Jun 23 at 04:42 PM
LENSAR (LNSR) Receives a Buy from BTIG
- Market Beat · May 9 at 03:37 PM
LENSAR (NASDAQ:LNSR) Announces Quarterly Earnings Results
- Earnings Watch · May 8 at 06:07 AM
Lensar - W/I | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 13.43 M
- Market Beat · Apr 14 at 10:28 PM
LENSAR, Inc. (NASDAQ:LNSR) Short Interest Update
